Recombinant factor VIIa in the management of pulmonary hemorrhage associated with metastatic choriocarcinoma.

Recombinant factor VIIa in the management of pulmonary hemorrhage associated with metastatic choriocarcinoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Recombinant factor VIIa in the management of pulmonary hemorrhage associated with metastatic choriocarcinoma. Abstract Text:

Matthew J Wheater,Graham M Mead,Sandeep Bhandari,Jonathan Fennell,

Recombinant factor VIIa in the management of pulmonary hemorrhage associated with metastatic choriocarcinoma. Publishing Authors By Initials

MJ Wheater,GM Mead,S Bhandari,J Fennell,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Recombinant factor VIIa in the management of pulmonary hemorrhage associated with metastatic choriocarcinoma. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of clinical oncology : official journal of

VOLUME: 26

Page Numbers: 1008-10

Journal Abbreviation: J. Clin. Oncol.

ISSN: 1527-7755

DAY: 20

MONTH: Feb

YEAR: 2008

Recombinant factor VIIa in the management of pulmonary hemorrhage associated with metastatic choriocarcinoma. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8309333

Recombinant factor VIIa in the management of pulmonary hemorrhage associated with metastatic choriocarcinoma. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Recombinant factor VIIa in the management of pulmonary hemorrhage associated with metastatic choriocarcinoma. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Recombinant factor VIIa in the management of pulmonary hemorrhage associated with metastatic choriocarcinoma.

AFFILIATION: Department of Medical Oncology, Southampton General Hospital, Southampton, United Kingdom.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Clin Oncol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Recombinant factor VIIa in the management of pulmonary hemorrhage associated with metastatic choriocarcinoma Related Publications

• "Drinking is Fun" and "There's Nothing You Can Do About It": The Problem With the 21-Year-Old Minimum Drinking Age.
• Best interests and treatment for mental disorder.
• Cytopathology of choricallantoic lesions induced by saline suspensions of colpidia and various types of colpidian extracts.
• Dechlorination and detoxification of 1,2,3,4,7,8-hexachlorodibenzofuran by a mixed culture containing Dehalococcoides ethenogenes Strain 195.
• Dynamical systems analysis of mitochondrial BAK activation kinetics predicts resistance to BH3 domains.
• Exploring co-management theory: prospects for sociobiology and reciprocal altruism.
• Human rights, bioethics, and mental disorder.
• In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion.
• Machine vision based stochastic analysis of cancer cell mitochondrial dysfunction induced by a BH3 domain.
• New species of Penicillium.
• Recombinant factor VIIa in the management of pulmonary hemorrhage associated with metastatic choriocarcinoma.
• Sexuality and the commission of physical violence to partners and non-partners by men and women.
• Synergy, influence, and information in the adoption of administrative innovations.
• The new medical technologies and the organizations of medical science and treatment.